semaglutide approved for obesity The FDA has a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing European Commission Approves 7.2 mg

human lifespan trials do not)6 Optimal dosing windows, cycling duration, and rest intervals for stacked protocols The Frontiers in Aging 2026 review stated the limitation clearly: significant knowledge gaps include optimal dosing regimens, combination therapy effects, and biomarkers for monitoring efficacy.2 This is why supervised clinical protocols with regular lab monitoring and dose titration are not optional

It is offered exclusively for research applications and must be handled by trained professionals in certified laboratory settings.

Bile acids attenuate PKM2 pathway activation in proinflammatory microglia

High levels of visceral fat are associated with diabetes, heart disease, fatty liver disease, and other metabolic conditions

This suggests that for many people, it's more of a long-term treatment than a short-term fix